Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
26 July 2017
Answer given by President Juncker on behalf of the Commission

1+2. The Commission would refer the Honourable Member to the Procedure leading up to a decision on the relocation of the European Medicines Agency and the European Banking Authority, endorsed by the Heads of State or Government of 27 Member States in the margins of the European Council (Article 50) held on 22 June 2017(1).

3. As regards the bearing of the costs of the relocation, point III.2 of the directives for the negotiation of an agreement with the United Kingdom(2) states that ‘the United Kingdom should fully cover the specific costs related to the withdrawal process such as the relocation of the agencies or other Union bodies’. No relevant estimate of the cost of the relocation can be made at this time because essential factors remain to be established.

(2)Annex to the European Commission Recommendation of 3.5.2017 for a Council Decision authorising the opening of the negotiations for an agreement with the United Kingdom of Great Britain and Northern Ireland setting out the arrangements for its withdrawal from the European Union [COM(2017) 218 final].

Last updated: 4 August 2017Legal notice